
Sign up to save your podcasts
Or
On Episode 9 of the Modern BioPharma Podcast we have Merrilee Whitney from MilliporeSigma on to discuss the launch of the BioContinuum Platform.
The current paradigm shift and digital transformation in biomanufacturing will result in a facility of the future that is truly an ecosystem of intensified, connected & continuous processing seamlessly coupled with uninterrupted data acquisition and analysis. Together, this will make real-time lot release and lights-out manufacturing achievable to the ultimate benefit of patients around the globe, expanding access to affordable life-saving and life-enhancing biotherapeutics. Merrilee Whitney is the Head of the BioContinuum Platform at MilliporeSigma.
This episode is also available on YouTube at: https://youtu.be/ehVnDIDCLio
You can find Merrilee on LinkedIn at: https://www.linkedin.com/in/merrilee-whitney-02aa939/
Want to learn more? Check out their site at https://www.emdmillipore.com/US/en/20180329_155610
5
77 ratings
On Episode 9 of the Modern BioPharma Podcast we have Merrilee Whitney from MilliporeSigma on to discuss the launch of the BioContinuum Platform.
The current paradigm shift and digital transformation in biomanufacturing will result in a facility of the future that is truly an ecosystem of intensified, connected & continuous processing seamlessly coupled with uninterrupted data acquisition and analysis. Together, this will make real-time lot release and lights-out manufacturing achievable to the ultimate benefit of patients around the globe, expanding access to affordable life-saving and life-enhancing biotherapeutics. Merrilee Whitney is the Head of the BioContinuum Platform at MilliporeSigma.
This episode is also available on YouTube at: https://youtu.be/ehVnDIDCLio
You can find Merrilee on LinkedIn at: https://www.linkedin.com/in/merrilee-whitney-02aa939/
Want to learn more? Check out their site at https://www.emdmillipore.com/US/en/20180329_155610